| Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment C Cicognola, S Janelidze, J Hertze, H Zetterberg, K Blennow, ... Alzheimer's research & therapy 13, 1-9, 2021 | 173 | 2021 |
| Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease C Cicognola, G Brinkmalm, J Wahlgren, E Portelius, J Gobom, NC Cullen, ... Acta neuropathologica 137, 279-296, 2019 | 153 | 2019 |
| Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology K Blennow, C Chen, C Cicognola, KR Wildsmith, PT Manser, ... Brain 143 (2), 650-660, 2020 | 84 | 2020 |
| Propagation of tau pathology: integrating insights from postmortem and in vivo studies T Vogels, A Leuzy, C Cicognola, NJ Ashton, T Smolek, M Novak, ... Biological psychiatry 87 (9), 808-818, 2020 | 81 | 2020 |
| Comparing the clinical utility and diagnostic performance of CSF P-Tau181, P-Tau217, and P-Tau231 assays A Leuzy, S Janelidze, N Mattsson-Carlgren, S Palmqvist, D Jacobs, ... Neurology 97 (17), e1681-e1694, 2021 | 75 | 2021 |
| Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson’s diagnosis and prognosis L Parnetti, C Cicognola, P Eusebi, D Chiasserini Biomarkers in medicine 10 (1), 35-49, 2016 | 65 | 2016 |
| Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease A Leuzy, C Cicognola, K Chiotis, L Saint-Aubert, L Lemoine, N Andreasen, ... European journal of nuclear medicine and molecular imaging 46, 1152-1163, 2019 | 36 | 2019 |
| Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest MS Foiani, C Cicognola, N Ermann, IOC Woollacott, C Heller, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (7), 740-746, 2019 | 32 | 2019 |
| Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217 C Groot, C Cicognola, D Bali, G Triana-Baltzer, JL Dage, MJ Pontecorvo, ... Alzheimer's research & therapy 14 (1), 67, 2022 | 30 | 2022 |
| Preanalytical confounding factors in the analysis of cerebrospinal fluid biomarkers for Alzheimer’s disease: the issue of diurnal variation C Cicognola, D Chiasserini, L Parnetti Frontiers in neurology 6, 143, 2015 | 28 | 2015 |
| No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF C Cicognola, D Chiasserini, P Eusebi, U Andreasson, H Vanderstichele, ... Molecular neurodegeneration 11, 1-9, 2016 | 23 | 2016 |
| Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias C Cicognola, O Hansson, P Scheltens, H Kvartsberg, H Zetterberg, ... Alzheimer's Research & Therapy 13, 1-12, 2021 | 19 | 2021 |
| Associations of CSF PDGFRβ with aging, blood-brain barrier damage, Neuroinflammation, and Alzheimer disease pathologic changes C Cicognola, N Mattsson-Carlgren, D van Westen, H Zetterberg, ... Neurology 101 (1), e30-e39, 2023 | 16 | 2023 |
| Tauopathy-associated tau fragment ending at amino acid 224 is generated by Calpain-2 cleavage C Cicognola, TM Satir, G Brinkmalm, I Matečko-Burmann, L Agholme, ... Journal of Alzheimer's Disease 74 (4), 1143-1156, 2020 | 9 | 2020 |
| Effects of APOE genotype, age and sex on cerebrospinal fluid biomarkers measured with NeuroToolKit in the Longitudinal Swedish Biofinder Cohort C Cicognola, S Janelidze, S Palmqvist, I Suridjan, G Kollmorgen, ... Alzheimer's & Dementia 17, e055153, 2021 | 1 | 2021 |
| Plasma GFAP in schizophrenia C Cicognola, A Santillo, D Eratne, M Kang, O Hansson, P Lorenzo, ... OSF, 2024 | | 2024 |
| A Retrospective Study on Clinical Assessment of Cognitive Impairment in a Swedish Cohort: Is There Inequality Between Natives and Foreign-Born? E Nyholm, R Torkpoor, K Frölich, E Londos, C Cicognola Journal of Alzheimer's Disease 89 (4), 1403-1412, 2022 | | 2022 |
| F4‐02‐03: TAU FLUID BIOMARKERS: STATE‐OF‐THE‐ART AND NOVEL FINDINGS IN AD AND PRIMARY TAUOPATHIES C Cicognola Alzheimer's & Dementia 15, P1219-P1219, 2019 | | 2019 |
| P4‐135: NATIVE GEL OVERLAY WITH FRET SUBSTRATE AND MS OF IN‐GEL DIGESTED ACTIVE BANDS SHOW THAT CALPAIN‐2 IS RESPONSIBLE FOR TAU CLEAVAGE AT AMINO ACID 224 C Cicognola, B Becker, G Brinkmalm, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15, P1327-P1327, 2019 | | 2019 |
| P2‐237: IMMUNOHISTOCHEMICAL PROFILING OF PRIMARY TAUOPATHIES MS Foiani, T Jackson-Morgan, C Cicognola, N Ermann, AJ Heslegrave, ... Alzheimer's & Dementia 15, P671-P672, 2019 | | 2019 |
Oskar HanssonProfessor of Neurology, Lund University在 med.lu.se 的电子邮件经过验证
